Back to Search
Start Over
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study.
- Source :
- Cancer (0008543X); Feb1995, Vol. 75 Issue 3, p815-820, 6p
- Publication Year :
- 1995
Details
- Language :
- English
- ISSN :
- 0008543X
- Volume :
- 75
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Cancer (0008543X)
- Publication Type :
- Academic Journal
- Accession number :
- 62869927
- Full Text :
- https://doi.org/10.1002/1097-0142(19950201)75:3<815::AID-CNCR2820750311>3.0.CO;2-R